Bermele Share Discussion Threads

[garreyd] 19/7/2021 15:16

Where's the damn prospectus son? Ain't uploaded it. Sleeping at the wheel like

[garreyd] 06/7/2021 01:26

Dunno about you but im getting a real stuff on thinking about this deal. Could be a masterstroke. Only taken half a decade to put together lol. Just hope we dont see the usual pump n dump yknow. Between me n the lads reckon we got bout 200k in BERM. Hold on open n see where it takes us. As ye were

[fred162] 21/6/2021 14:34

Interesting 3rd Man. Regan's brother works for Optiva Securities so should be no problem raising the dosh. But what's taking so long?

[thirdmanharry] 21/6/2021 14:31

Article in THe Times 2 June 2021 reported:
"A New Zealand-based supplier of upmarket mixers that is aiming to establish itself as a global No 2 to Fever-Tree Drinks is set to list on Aim with a market value of £30 million.
East Imperial, co-founded in 2012 by Tony Burt, a former chief executive of M&C Saatchi New Zealand, is listing by means of a reverse takeover of Bermele, a cash shell, in which Burt, 50, will emerge with a 21.4 per cent stake.
Alongside the listing, East Imperial, which is being advised by Optiva Securities, a boutique broker, will raise £3 million of new funds through a placing of 30 million shares at 10p a share to finance its growth ambitions.
Like Fever-Tree, East Imperial prides itself on the quality of its ingredients, with its tonic water containing quinine from the bark of cinchona trees hand- picked in Java. Its other mixers include yuzu and grapefruit tonics, Mombasa Ginger Beer and Kima Kola, which has allowed it to target the dark spirits market. The company also has a collaboration with the Royal Botanic Gardens in London called Royal Botanic Tonic.
Other strands to its business include an organic tonic and low-calorie flavoured soda waters, including pineapple and kombu and blueberry and white tea ranges. It is also poised to launch a coffee and tonic drink after completing trials.
Although it does not sell its drinks in Britain, where Fever-Tree has a dominant position, it is taking on its bigger rival in much of Asia-Pacific, including China, and in the United States. It has a modest presence in Europe.
Whereas Fever-Tree sells to both “on-trade̶1; buyers — bars, pubs and restaurants — and supermarkets, East Imperial’s main customers are five-star hotels and premium bars and restaurants. The lockdowns have driven a surge in sales through its website. Its most prestigious customers include the Mondrian South Beach, in Miami, the Peninsula in Chicago and the Ritz-Carlton, Shanghai, as well as the Atlas Bar in Singapore.
According to its presentation, in 2019 it was rated the No 3 top trending tonic brand as well as the No 3 top selling tonic brand by Drinks International, the industry magazine, based on votes from the world’s top 50 bars.
The company reported revenue of £2.68 million in 2019, which fell to £1.75 million last year because of the pandemic. Its operating losses narrowed from £853,000 to £813,000, while pre-tax losses fell from £888,000 to £850,000.
Bermele, which will change its name to East Imperial, was floated on Aim in May 2019 to acquire businesses in the pharmaceutical and biotechnology sector and last year it widened the search for targets to other sectors. Last July it entered exclusive talks over a reverse takeover by East Imperial."

[garreyd] 16/6/2021 15:54

Most strange timing of that article?? Usually their team get the token 'final paragraph of the business section' article out the day prior to the deal closing?

[thirdmanharry] 08/6/2021 10:12

Why the delay in announcing the deal? It was fully set out in The Times at the weekend

[garreyd] 04/6/2021 09:32

Yeh I'm getting a lob on for this one son. Reckon we could be lookin at a 5x in first 12 months. Just need a gd start - clear the sellers out day 1 and ride the wave. Could well be some strong institutional interest y'know. As ye were

[fred162] 17/5/2021 15:13

Accounts now published and the mystery provider of the convertible loan is stated to be Pascal Hughes an ex-director of Leverett of the cash shell formed by Regan/Corvus into which Nuformix reversed. Happy days ahead (but what's taking so long?).

[geoff80] 24/3/2021 13:35

For Immediate Release 8 March 2021

Bermele Plc

("Bermele" or "the Company")

Convertible Loan Agreement

Bermele has entered into a Convertible Loan Agreement for GBP100,000 ("Loan") with a private investor. The Loan, which is for a fixed term of 12 months and carries no interest, is repayable or convertible at the Lender's discretion into new Ordinary Shares in the Company at 0.6 pence per share.

The proceeds from the Loan are to be used for working capital pending completion of the potential acquisition of East Imperial Pte. Ltd as announced by the Company on 20 July 2020. Preparations for the publication of a prospectus and admission of the enlarged group to trading on the London Stock Exchange are well advanced.

The transaction remains conditional, inter alia, on consent from the Financial Conduct Authority for the re-admission of the enlarged share capital to the Official List (by way of Standard Listing under Chapter 14 of the Listing Rules).

[garreyd] 10/2/2021 14:04

This deal still giving me a hard on. It'll be huge when it comes back

[fred162] 08/10/2020 11:14

The company which was formed to acquire a target company (or companies) with realisable or developed commercial technologies in the pharmaceutical and biotechnology sector, is now to acquire....a fizzy drink business! You couldnt make it up...

[garreyd] 27/7/2020 09:13

This could be a quite beautiful transaction if they get it right. East Imperial have a strong footprint in Asia and could act as a stern competitor to Fevertree as a premium mixer alternative. Watch this space...

[2magpies] 20/7/2020 08:03

Goodness! Is this a new 'Fevertree'??.

[fred162] 14/5/2020 18:24

Been a year since listing. What’s taking so long...

[imjustdandy] 30/4/2020 05:48

Exactly Fresh. So under the Radar and Bio RTO on the cards. Won't be 1.25 for much longer. Next covid bagger and some

[imjustdandy] 29/4/2020 21:02

5p on the cards very soon

[imjustdandy] 29/4/2020 16:43

Over 5m shares traded today and up 25%. Nice Covid - 19 play under £2m Mkt Cap

[jfreshfield] 29/4/2020 16:09

Great volume day. Looking for strong week here as people work out what could happen here. Covid 19 asset surely close

[geoff80] 29/4/2020 09:13

Certainly worth a punt.

[geoff80] 29/4/2020 09:11

Worth a punt.

[imjustdandy] 29/4/2020 08:00

Not many sub 2m mkt caps left in the Pharma space.

[imjustdandy] 29/4/2020 07:46

£2m Mkt Cap .